JP2000511888A5 - - Google Patents

Download PDF

Info

Publication number
JP2000511888A5
JP2000511888A5 JP1997540229A JP54022997A JP2000511888A5 JP 2000511888 A5 JP2000511888 A5 JP 2000511888A5 JP 1997540229 A JP1997540229 A JP 1997540229A JP 54022997 A JP54022997 A JP 54022997A JP 2000511888 A5 JP2000511888 A5 JP 2000511888A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997540229A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000511888A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/007874 external-priority patent/WO1997041863A1/en
Publication of JP2000511888A publication Critical patent/JP2000511888A/ja
Publication of JP2000511888A5 publication Critical patent/JP2000511888A5/ja
Ceased legal-status Critical Current

Links

JP09540229A 1996-05-09 1997-05-08 混合キメリズム及び寛容 Ceased JP2000511888A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1709996P 1996-05-09 1996-05-09
US60/017,099 1996-05-09
PCT/US1997/007874 WO1997041863A1 (en) 1996-05-09 1997-05-08 Mixed chimerism and tolerance

Publications (2)

Publication Number Publication Date
JP2000511888A JP2000511888A (ja) 2000-09-12
JP2000511888A5 true JP2000511888A5 (cg-RX-API-DMAC10.html) 2005-01-13

Family

ID=21780711

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09540229A Ceased JP2000511888A (ja) 1996-05-09 1997-05-08 混合キメリズム及び寛容

Country Status (9)

Country Link
US (4) US6006752A (cg-RX-API-DMAC10.html)
EP (1) EP0918524A4 (cg-RX-API-DMAC10.html)
JP (1) JP2000511888A (cg-RX-API-DMAC10.html)
AT (1) ATE245990T1 (cg-RX-API-DMAC10.html)
AU (1) AU734665B2 (cg-RX-API-DMAC10.html)
CA (1) CA2253597A1 (cg-RX-API-DMAC10.html)
DE (1) DE69723888T2 (cg-RX-API-DMAC10.html)
ES (1) ES2201977T3 (cg-RX-API-DMAC10.html)
WO (1) WO1997041863A1 (cg-RX-API-DMAC10.html)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871728A (en) 1995-03-31 1999-02-16 University Of Pittsburgh Method of regulating dendritic cell maturation
WO1997041863A1 (en) * 1996-05-09 1997-11-13 The General Hospital Corporation Mixed chimerism and tolerance
JP2001523645A (ja) * 1997-11-14 2001-11-27 ザ・ゼネラル・ホスピタル・コーポレイション 血液学的疾患の処置
IL137361A0 (en) 1998-02-04 2001-07-24 Gen Hospital Corp Inhibitors of the cd40 ligand-cd40 interaction
ATE316795T1 (de) * 1998-03-18 2006-02-15 Osiris Therapeutics Inc Mesenchymale stammzellen für die prävention und behandlung von immunantworten bei transplantationen
US6469229B1 (en) 1998-08-20 2002-10-22 The General Hospital Corporation Inbred miniature swine and uses thereof
AU2980900A (en) 1999-02-04 2000-08-25 General Hospital Corporation, The Methods for human allografting
WO2000054786A1 (en) * 1999-03-15 2000-09-21 Modex Therapeutiques, S.A. Methods and compositions for tolerizing hosts for long term survival of tissue transplants
US6750023B2 (en) * 1999-09-02 2004-06-15 Corning Incorporated Porous inorganic substrate for high-density arrays
AU778929B2 (en) * 1999-12-06 2004-12-23 General Hospital Corporation, The Pancreatic stem cells and their use in transplantation
WO2001053825A1 (en) * 2000-01-19 2001-07-26 Biotransplant, Inc. Swine defective for transmission of porcine endogenous retrovirus and uses thereof
AU2002239294B2 (en) * 2000-11-22 2006-05-11 Asterias Biotherapeutics, Inc. Tolerizing allografts of pluripotent stem cells
WO2002074938A1 (en) * 2001-03-20 2002-09-26 Trustees Of Amherst College Methods for producing antibodies in mammals
US20030044398A1 (en) * 2001-03-20 2003-03-06 Robl James M. Methods for producing antibodies in mammals
US20020152490A1 (en) * 2001-04-12 2002-10-17 Philip Lake Tolerance-inducing thy-marrow composite tissue construct and organ
US20030031652A1 (en) * 2001-04-16 2003-02-13 Bernhard Hering Systems and methods for inducing mixed chimerism
US20030032631A1 (en) * 2001-08-13 2003-02-13 Mcdonald George B. Method of treatment of cancer by controlling graft-versus-leukemia using topical active corticosteriods
WO2003099330A1 (en) * 2002-05-22 2003-12-04 The Cleveland Clinic Foundation Induction and maintenance of tolerance to composite tissue allografts
US20050058641A1 (en) * 2002-05-22 2005-03-17 Siemionow Maria Z. Tolerance induction and maintenance in hematopoietic stem cell allografts
WO2005021734A2 (en) * 2003-09-02 2005-03-10 University Of Massachussets Generation of hematopoietic chimerism and induction of central tolerance
US20050266001A1 (en) * 2004-04-02 2005-12-01 Hadley Gregg A Therapeutic blockade of CD103 interactions to prevent clinical renal allograft rejection
US20060148080A1 (en) * 2004-12-30 2006-07-06 Paul Diamond Methods for supporting and producing human cells and tissues in non-human mammal hosts
US20060147429A1 (en) * 2004-12-30 2006-07-06 Paul Diamond Facilitated cellular reconstitution of organs and tissues
US20070113297A1 (en) * 2005-09-13 2007-05-17 Yongguang Yang Methods and compositions for inhibition of immune responses
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
US8574567B2 (en) * 2007-05-03 2013-11-05 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
WO2008137115A1 (en) 2007-05-03 2008-11-13 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2013163176A1 (en) 2012-04-23 2013-10-31 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
KR20150132196A (ko) 2013-02-26 2015-11-25 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 이식편의 이식 관용을 위한 합동된 장기와 조혈 세포
AU2014248090B2 (en) 2013-04-03 2018-08-02 N-Fold Llc Novel nanoparticle compositions
GB201413240D0 (en) 2014-07-25 2014-09-10 Hansa Medical Ab Method
BR112019021977A2 (pt) 2017-04-20 2020-06-16 Egenesis, Inc. Métodos para a geração de animais geneticamente modificados
WO2019178106A1 (en) 2018-03-12 2019-09-19 Medeor Therapeutics, Inc. Methods for treating non-cancerous disorders using hematopoietic cells
US10842821B2 (en) 2018-04-05 2020-11-24 Medeor Therapeutics, Inc. Cellular compositions derived from prior organ donors and methods of manufacture and use thereof
US10881692B2 (en) 2018-04-05 2021-01-05 Medeor Therapeutics, Inc. Compositions for establishing mixed chimerism and methods of manufacture thereof
US11435350B2 (en) 2018-09-18 2022-09-06 Medeor Therapeutics, Inc. Methods of analysis of blood from deceased donors
US11813376B2 (en) 2018-09-18 2023-11-14 Medeor Therapeutics, Inc. Cellular compositions derived from deceased donors to promote graft tolerance and manufacture and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993013785A1 (en) * 1992-01-08 1993-07-22 The General Hospital Corporation Induced tolerance to xenografts
US5658564A (en) * 1992-02-19 1997-08-19 The General Hospital Corporation Xenograft thymus
US5876708A (en) * 1992-02-19 1999-03-02 The General Hospital Corporation Allogeneic and xenogeneic transplantation
US5597563A (en) * 1992-09-04 1997-01-28 Beschorner; William E. Method induction of antigen-specific immune tolerance
IL107483A0 (en) * 1993-11-03 1994-02-27 Yeda Res & Dev Bone marrow transplantation
WO1997041863A1 (en) * 1996-05-09 1997-11-13 The General Hospital Corporation Mixed chimerism and tolerance
IL137361A0 (en) * 1998-02-04 2001-07-24 Gen Hospital Corp Inhibitors of the cd40 ligand-cd40 interaction

Similar Documents

Publication Publication Date Title
JP2000502280A5 (cg-RX-API-DMAC10.html)
JP2000501771A5 (cg-RX-API-DMAC10.html)
JP2000501599A5 (cg-RX-API-DMAC10.html)
JP2000505452A5 (cg-RX-API-DMAC10.html)
JP2000500076A5 (cg-RX-API-DMAC10.html)
JP2000501324A5 (cg-RX-API-DMAC10.html)
JP2000500055A5 (cg-RX-API-DMAC10.html)
JP2000500026A5 (cg-RX-API-DMAC10.html)
JP2000502472A5 (cg-RX-API-DMAC10.html)
JP2000501338A5 (cg-RX-API-DMAC10.html)
JP2000501825A5 (cg-RX-API-DMAC10.html)
JP2000515570A5 (cg-RX-API-DMAC10.html)
JP2000502425A5 (cg-RX-API-DMAC10.html)
JP2000502485A5 (cg-RX-API-DMAC10.html)
JP2000502568A5 (cg-RX-API-DMAC10.html)
JP2000501774A5 (cg-RX-API-DMAC10.html)
JP2000502570A5 (cg-RX-API-DMAC10.html)
JP2000501876A5 (cg-RX-API-DMAC10.html)
JP2000511888A5 (cg-RX-API-DMAC10.html)
JP2000514140A5 (cg-RX-API-DMAC10.html)
JP2000501744A5 (cg-RX-API-DMAC10.html)
JP2000501229A5 (cg-RX-API-DMAC10.html)
JP2000502316A5 (cg-RX-API-DMAC10.html)
JP2000502714A5 (cg-RX-API-DMAC10.html)
JP2000514419A5 (cg-RX-API-DMAC10.html)